Treatment with JAK inhibitors prevented the degeneration of dopaminergic neurons in an in vivo model of Parkinson ́s disease and attenuated the IFN-γ-induced changes in cultured microglia and in isolated microglia prepared from APP/PS1 Alzheimer ́s mice [117,118]. This evidence concerns the gene IFNG and Parkinson disease.